OMIA:002441-9986 : Short QT syndrome, KCNH2-related in Oryctolagus cuniculus (rabbit)

Categories: Cardiovascular system phene

Links to possible relevant human trait(s) and/or gene(s) in OMIM: 609620 (trait) , 152427 (gene)

Single-gene trait/disorder: yes

Disease-related: yes

Key variant known: no

Species summary: This phene includes references to studies involving genetically modified organisms (GMO).

Genetic engineering: Yes - variants have been created artificially, e.g. by genetic engineering or gene editing
Have human generated variants been created, e.g. through genetic engineering and gene editing

Associated gene:

Symbol Description Species Chr Location OMIA gene details page Other Links
KCNH2 potassium voltage-gated channel, subfamily H (eag-related), member 2 Oryctolagus cuniculus 7 NC_091438.1 (22832727..22865322) KCNH2 Ensembl, NCBI gene

Contact us

If you notice anything missing or in need of change, please contact us at: [email protected].

Cite this entry

Nicholas, F. W., Tammen, I., & Sydney Informatics Hub. (2023). OMIA:002441-9986: Online Mendelian Inheritance in Animals (OMIA) [dataset]. https://omia.org/. https://doi.org/10.25910/2AMR-PV70

References

Note: the references are listed in reverse chronological order (from the most recent year to the earliest year), and alphabetically by first author within a year.

2025 Nimani, S., Bains, S., Alerni, N., Ördög, B., Horváth, A., Matas, L., Louradour, J., Giammarino, L., Tester, D.J., Beslac, O., Lopez, R., Meier, S., Egle, M., Christoforou, N., Barbieri, M., Vashanthakumar, V., Perez-Feliz, S., Parodi, C., Garcia Casalta, L.G., Kim, C.S.J., Zhou, W., Ye, D., Jurgensen, J., Barry, M.A., Bego, M., Keyes, L., Owens, J., Pinkstaff, J., Christoph, J., Zehender, M., Brunner, M., Heijman, J., Casoni, D., Praz, F., Haeberlin, A., Brooks, G., Ackerman, M.J., Odening, K.E. :
AAV9-mediated KCNH2 suppression-replacement gene therapy in a transgenic rabbit model of type 1 short QT syndrome. Eur Heart J :ehaf660, 2025. Pubmed reference: 40884219. DOI: 10.1093/eurheartj/ehaf660.
2024 Bodi, I., Mettke, L., Michaelides, K., Hornyik, T., Meier, S., Nimani, S., Perez-Feliz, S., El-Battrawy, I., Bugger, H., Zehender, M., Brunner, M., Heijman, J., Odening, K.E. :
Beneficial normalization of cardiac repolarization by carnitine in transgenic SQT1 rabbit models. Cardiovasc Res 120:1550-1561, 2024. Pubmed reference: 39018021. DOI: 10.1093/cvr/cvae149.
2022 Hornyik, T., Rieder, M., Castiglione, A., Major, P., Baczko, I., Brunner, M., Koren, G., Odening, K.E. :
Transgenic rabbit models for cardiac disease research. Br J Pharmacol 179:938-957, 2022. Pubmed reference: 33822374. DOI: 10.1111/bph.15484.
2019 Odening, K.E., Bodi, I., Franke, G., Rieke, R., Ryan de Medeiros, A., Perez-Feliz, S., Fürniss, H., Mettke, L., Michaelides, K., Lang, C.N., Steinfurt, J., Pantulu, N.D., Ziupa, D., Menza, M., Zehender, M., Bugger, H., Peyronnet, R., Behrends, J.C., Doleschall, Z., Zur Hausen, A., Bode, C., Jolivet, G., Brunner, M. :
Transgenic short-QT syndrome 1 rabbits mimic the human disease phenotype with QT/action potential duration shortening in the atria and ventricles and increased ventricular tachycardia/ventricular fibrillation inducibility. Eur Heart J 40:842-853, 2019. Pubmed reference: 30496390. DOI: 10.1093/eurheartj/ehy761.

Edit History


  • Created by Imke Tammen2 on 27 Sep 2021
  • Changed by Imke Tammen2 on 18 Dec 2023